After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS

Stock Information for Clene Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Clene Inc.

Clene Reports Full Year 2025 Financial Results and Recent Operating Highlights
Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
Clene to Present at the Emerging Growth Conference
Presenting on Emerging Growth Conference 89 Day 1 on January 21; Register to live stream
Clene to Present at the Emerging Growth Conference
Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting
Clene Announces Registered Direct Offering of Over $28 Million

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.